The aim of this study was to establish mitochondrial cholesterol trafficking 18kDa translocator protein (TSPO) as a potential therapeutic target, capable of increasing macrophage cholesterol efflux to (apo)lipoprotein acceptors. Expression and activity of TSPO in human (THP-1) macrophages were manipulated genetically, and by the use of selective TSPO ligands. Cellular responses were analysed by quantitative PCR, immunoblotting and radiolabelling, including [ 3 H]cholesterol efflux to apoA-I, HDL and human serum. Induction of macrophage cholesterol deposition by acetylated LDL (AcLDL) increased expression of TSPO mRNA and protein, reflecting findings in human carotid atherosclerosis. Transient overexpression of TSPO protein enhanced efflux (E%) of [ 3 H]cholesterol to ApoA-I, HDL and human serum, compared with empty vector controls, while gene knockdown of TSPO achieved the converse. Ligation of TSPO (PK11195, FGIN-1-27, flunitrazepam) triggered increases in [ 3 H]cholesterol efflux, an effect which was amplified in TSPO overexpressing macrophages. Overexpression of TSPO induced expression of genes (PPARA, NR1H3, ABCA1, ABCG4, APOE) and proteins (ABCA1, PPAR) involved in cholesterol efflux, reduced macrophage neutral lipid mass and lipogenesis, and limited cholesterol esterification following exposure to AcLDL. Thus, targeting TSPO reduces macrophage lipid content and prevents macrophage foam cell formation, via enhanced cholesterol efflux to (apo)lipoprotein acceptors.
Introduction
Mitochondrial dysfunction, associated with increased production of reactive oxygen species, accumulation of mitochondrial DNA damage and progressive loss of respiratory chain function, is found in atherosclerotic lesions in both human studies, and in animal models of atherogenesis 1 .
Oxidized low density lipoprotein (OxLDL), ageing, hyperhomocysteinaemia, hyperglycaemia, hypertriglyceridaemia, type 2 diabetes mellitus and cigarette smoking are all associated with mitochondrial damage and increased production of reactive oxygen species [2] [3] [4] . Increased arterial oxidative stress modifies LDL to a form recognised by macrophage scavenger receptors, resulting in further mitochondrial damage, and the unregulated accumulation of excess cholesterol and cholesteryl esters within macrophage 'foam cells', hallmark of early and developing atheroma [1] [2] [3] [4] [5] . Reversal of this process, regressing and stabilising atherosclerotic lesions, can be effected by efficient removal of cholesterol from 'foam cells', to acceptor particles such as apolipoprotein (apo) A-I, apoE or nascent high density lipoproteins (HDL), which then enter the athero-protective reverse cholesterol transport pathway responsible for delivery of excess cholesterol to the liver for excretion in bile and bile acids 6 .
Recently, we 7 and others 8 , demonstrated that overexpression of mitochondrial cholesterol trafficking protein, steroidogenic acute regulatory protein (StAR), decreases macrophage lipid content 7,8 , represses inflammation 8 and increases macrophage cholesterol efflux 7, 8 , while a viral vector expressing StAR reduces aortic lipids and atheroma, in apoE -/mice 9 . Overexpression of StAR enhances the rate-limiting step in mitochondrial generation of oxysterol ligands for LXR: transfer of cholesterol to sterol 27-hydroxylase (CYP27A1) located on the inner mitochondrial membrane 10, 11 .
Sterol 27-hydroxylase generates oxysterol ligands for Liver X Receptors (LXR), nuclear transcription factors which regulate gene expression of proteins involved in the cholesterol efflux pathway, including ATP binding cassette transporters, ABCA1, ABCG1/ABCG4, which orchestrate transfer of cholesterol and/or phospholipids across the plasma membrane to (apo)lipoproteins, such as apoA-I and apoE [12] [13] [14] . Loss of CYP27A1 results in cerebrotendinous xanthomatosis, which can be characterised by increased risk of premature atherosclerosis, despite normal circulating concentrations of plasma LDL 15 .
Exploiting the anti-atherogenic functions of StAR may prove problematic, however, due either to induction of lipogenesis 7 or the dearth of small molecules capable of modulating the activity of this protein in vivo.
However, StAR interacts with a protein complex, located at contact sites between outer and inner mitochondrial membranes, which includes 18kDa translocator protein (TSPO/peripheral benzodiazepine receptor/PBR), voltage dependent anion channel (VDAC) and adenine nucleotide transporter (ANT), and associated proteins, including cAMP-dependent protein kinase associated protein (PAP7/ Acyl CoA binding domain-3/ACBD3), PBR-associated protein (PRAX1) and its proposed endogenous ligand, diazepam binding inhibitor (DBI/ACBD1) 16, 17 . The translocator protein TSPO regulates macrophage cholesterol efflux 4 has five transmembrane domains, and a high affinity cholesterol recognition amino acid (CRAC) binding C-terminal domain 16, 17 ; the CRAC peptide was recently used as an interchelating agent to reduce cholesterol and aortic lesions in apoE -/mice 18 . Knockdown of TSPO induces arrest of mitochondrial cholesterol transport, which can be rescued by TSPO cDNA, while global deletion of TSPO is embryonic lethal in mice 16, 17 . Intriguingly, TSPO ligands were recently shown to activate fasting metabolism, reducing lipogenesis and hepatosteatosis in obese mice 19 , suggesting that additional activities associate with this protein.
The contribution, and therapeutic potential, of TSPO and associated proteins in regulation of the cholesterol efflux pathway in macrophages and macrophage 'foam cells', remains uninvestigated, despite the potential importance of this pathway in activating the anti-atherogenic cholesterol efflux process. Here, we study gene and protein expression of TSPO during macrophage 'foam cell' formation, and demonstrate the positive impact of TSPO overexpression and/or ligation on macrophage cholesterol efflux; notably, TSPO overexpression causes a decline in macrophage total neutral lipid mass, without induction of lipogenesis, and effectively prevents 'foam cell' formation following exposure to acetylated LDL. We postulate that existing ligands for TSPO may possess antiatherosclerotic properties, readily amenable to testing in clinical studies.
Methods

Materials
Human monocytic cell line (THP-1) and murine RAW264. as previously described 7, 22, 23 . Cell viabilities were determined by conversion of methyl thiazolyl blue tetrazolium bromide to formazan, as previously 7,22, 23 . was assessed as previously described 24 . Neutral lipid mass (total cholesterol, triacylglycerol) in macrophage lipid extracts (above) were determined using colorimetric assays (Infinity™), and expressed as g lipid per mg cell protein 7, 20, 22, 23 . Macrophage efflux of [ 3 H]cholesterol to apoA-I (20 g ml -1 ), HDL (20 g ml -1 ) and human serum (1%, v/v) were determined as previously described 22, 23 . Efflux (24h) from radiolabelled macrophages was initiated 48h post-transfection by addition of serum-free RPMI containing each acceptor, and results are expressed as % cholesterol efflux, calculated as [dpm media /dpm (media + cells) ] x 100%.
Macrophage lipid analysis and cholesterol efflux
TSPO regulates macrophage cholesterol efflux macrophages to two doses of 50 g ml -1 AcLDL (24h), led to a modest but significant increase (27%;
p<0.05) in total cholesterol mass (control 58.0+1.7 g mg -1 cell protein versus AcLDL 73.7+7.2 g mg -1 cell protein; p<0.05; n=4), a mild cholesterol loading condition that avoids the overt toxicity associated with exposure to higher concentrations of modified LDL 25 . Levels of mRNA encoding TSPO were increased by 1.8±0.3-fold following exposure to AcLDL, reflected in increased levels of TSPO protein (37%; p<0.05; n=3), relative to VDAC or GAPDH (Figure 1B) . Analysis 
Ligation of TSPO increases macrophage cholesterol efflux to apoA-I and HDL
Wild type THP-1 macrophages were treated with established TSPO ligands, PK11195, FGIN-1-27
and flunitrazepem, using concentrations commonly utilised to increase mitochondrial cholesterol trafficking and steroidogenesis 16, 17 . Significant increases in The ability of TSPO overexpression (48h) to increase cholesterol efflux, and protect macrophages against accumulation of cholesteryl ester was investigated following exposure to AcLDL (50g ml -1 )
for 24h (Figures 4C and 4D) . (Figure 6A) and by treatment with siRNA (10nM) directed against PPAR (Figure 6B) , allow us to posit the pathway described in Figure 6C .
Discussion
This study investigated the relationship between components of the mitochondrial cholesterol trafficking and macrophage cholesterol homeostasis, and demonstrated that overexpression, gene silencing and ligation of mitochondrial TSPO modulate cholesterol efflux, with TSPO overexpression channelling cholesterol away from the cholesteryl ester pool and reducing macrophage total neutral lipid mass, without triggering compensatory increases in lipogenesis. These effects appear to be related to the induction and/or activation of LXR and PPAR caused by TSPO overexpression or ligation: blockade of either pathway using antagonists and/or siRNA directed against these transcription factors prevented the TSPO-dependent increases in cholesterol efflux.
Overexpression of the 18kDa translocator protein (TSPO) is associated with increased efflux of cholesterol to apoA-I and HDL, and induction of expression of genes involved in the cholesterol efflux pathway 7, 8 , including NR1H3, ABCA1, ABCG4, but not ABCG1 (Figure 5) . The reason for this distinctive regulatory pattern is not clear at present, but dissociation of ABCA1 and ABCG1 gene expression has been noted in bovine mammary tissue during the switch from lactating to dry to periods 27 . Induction of LXR is consistent with sequestration of SREBP2 protein at the endoplasmic reticulum, and loss of SREBF2 expression ( Figure 5A) : both may contribute to increased induction of ABCA1 mRNA and protein [29] [30] [31] . Expression of ABCG4 in human monocyte-macrophages lies under the control of oxysterols and retinoids 31 suggesting this gene and ABCA1 may both be regulated by LXR activation or induction (Figure 5A) , and one mechanism by which [ 3 H]cholesterol efflux to HDL is increased (Figure 2B) .
Moreover, overexpression of TSPO and/or ligation of this protein by FGIN-1-27, induced PPAR alpha gene and/or protein levels, previously associated with increased ABCA1 expression and cholesterol efflux [32] [33] [34] [35] . Expression of PPAR can be regulated by stress, hormones and starvation in rodents, while human PPAR can mediate its own expression, and is induced during macrophage differentiation in response to high glucose levels 33 . Notably, the PPARpromoter can be activated by PPAR agonists in an LXR dependent manner, and LXR is a PPAR target 35 , so that these transcription factors can work together in a cooperative manner to control ABCA1 expression and cholesterol efflux 32 . Overexpression of TSPO induces expression of LXR and PPAR, while use of either SiRNA or an antagonist directed against PPAR (GW6471) (Figure 6) indicates an obligate role for PPAR in mediating TSPO-dependent increases in [ 3 H]cholesterol efflux to apoA-I and possibly other cholesterol acceptors (Figure 2B) .
Indeed, the coordinated induction of PPAR and LXR by TSPO may be a key factor in abrogating the adverse effects previously associated with activation of LXR by agonists such as T091317 36 . In particular, our previous study 7 , reported that overexpression and activation of mitochondrial cholesterol trafficking protein, StAR, in murine macrophages, was associated not only with enhanced cholesterol efflux and increased expression of ABCA1, but also with substantive induction of lipogenesis, thereby limiting the potential therapeutic utility of this approach 7, 36 . By contrast, overexpression of TSPO was associated not only with increased cholesterol efflux to acceptors ( Figure 2B) but with a marked loss of macrophage neutral lipid content (Fig 4A) , and a small reduction in lipogenesis, primarily within the fatty acid pool (Fig 4B) . Further, and consistent with PPAR induction, levels of CPT-1A gene expression were increased, reflected in enhanced fatty acid oxidation, in TSPO overexpressing cells. Activation of PPAR is known to induce modest increases in lipogenesis, possibly via participation in the generation of an endogenous LXR ligand 35 , and enhances fatty acid oxidation, by inducing the expression of long chain fatty acyl CoA synthetases and carnitine palmitoyl transferase-1, essential for generating fatty acyl CoA and facilitating the entry of fatty acyl carnitine into mitochondria for -oxidation [32] [33] [34] . These data provide a plausible explanation for the observed reductions in macrophage triacylglycerol content ( Figure 4A) and [ 14 C]fatty acid levels (Fig 4B) . Overexpression of TSPO was also associated with reduced incorporation of [ 3 H]oleate into the cholesteryl ester pool, and with decreased total cholesterol mass, following exposure to modified LDL (Fig 4D) , which may reflect the reduced availability of de novo synthesized fatty acids for esterification (Fig 4B) [32] [33] [34] ; indeed, activation of PPAR and LXR have previously been associated reductions in ACAT activity and cholesterol esterification in human macrophages 32, 33 .
Notably, treatment with acetylated LDL appears to reflect the induction of TSPO observed in human carotid atherosclerotic plaques, wherein binding of TSPO ligands such as [ 3 H]PK11195 and [ 3 H]DAA1106 have been shown to significantly correlate with macrophage burden 37 . Lipid regulation of TSPO gene expression has not previously been reported during macrophage cholesterol loading, but Tspo can be regulated by protein kinase C by downstream signalling pathways involving mitogen-activated protein kinase MAPK (Raf-ERK1/2), and by acting on targets such as c-Jun, and the signal transducer and activator of transcription 3 (STAT3) 16, 17 . It is known that STAT3 gene delivery can reduce atherosclerotic lesions in LDL receptor knockout mice fed a high cholesterol diet 37 , but whether induction of TSPO forms part of that response is not established. However, it is known that expression of TSPO is modulated by PPARs in a tissue specific manner, with transrepression of Tspo by PPAR cited in Leydig cells, but the reverse noted in non-steroidogenic tissues 17 . Given the presence of a number of putative PPAR response elements within the promoter region of TSPO, it is possible to speculate that induction of PPAR in human macrophages may form part of a feed-forward regulatory loop, sustaining or amplifying TSPO expression ( Figure 6) .
Finally, the ability of TSPO to moderate gene transcription, has been observed in lower species, and thus may be evolutionarily conserved in mammalian cells. For example, the bacterial ortholog, TspO outer membrane protein, found in Rhodobacter sphaeroides, which is involved in effluxing intermediates of the porphyrin biosynthetic pathway, acts as a co-activator of transcription of a number of genes, encoding enzymes involved in photopigment biosynthesis 39, 40 . Arabidopsis TSPO is also linked to porphyrin metabolism, and appears to act as a signal linking water-related stress to transient increases in gene expression of the plant stress hormone, absicisc acid 41 .
Summary
We 
Author contribution
The study was originated and designed by AG, in consultation with JMT; JMT performed the majority of the laboratory work, with additional input from AMA. All three authors have been involved in preparation of the manuscript.
Funding
This work was supported by a project grant from the British Heart Foundation PG/04/0002871. Figure 1B . Values are mean±SEM, and significance between expression in macrophages and macrophage 'foam' cells was determined by Student's t-test. Figure   1C shows AcLDL-induced expression of TSPO protein, relative to VDAC and GAPDH (n=3; *p<0.05) as assessed by ECL detection. Figure 2B shows the knockdown ( is shown in Figure 2C . Figure 2D shows the effect of siRNA (10nM) directed against TSPO on efflux of [ 3 H]cholesterol to apoA-I (20g ml -1 ; n=4) and HDL (20g ml -1 ; n=4). Values are mean±SEM; significant differences due to genetic manipulation of TSPO were determined using Students' t-test and are as indicated on Figure 2C and 2D.
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Figure 2
Figure 3
The effect of TSPO ligands, PK11195 (30M; n=3) and flunitrazepam (30M; n=3), on the efflux of [ 3 H]cholesterol to apoA-I (20g ml -1 ) and HDL (20g ml -1 ) are shown in Figure 3A and 3B, respectively. Figure 3C shows n=4) in empty vector and TSPO-transfected macrophages previously exposed to a cholesterol load (AcLDL, 24h, 50g ml -1 ) is shown in Figure 4C ; significant differences were determined by one way ANOVA and Bonferroni post-test. The incorporation of [ 3 H]oleate (1Ci ml -1 ; 10M; n=3) into the cholesteryl ester pool in empty vector and TSPO transfected macrophages, and in the absence or presence of AcLDL (50g ml -1 ; 24h) is shown in the upper panel of Figure 4D , while the total cholesterol mass, investigated in the presence of AcLDL (50g ml -1 ; 24h; n=3), is shown in the lower panel of Figure 4D Figure 5B (n=3; *p<0.05). The immunoblots for ABCA1 and ACAT1 were generated using ECL detection, while that for PPARutilised fluorescently labelled secondary antibody and LI-COR software (Methods).
Figure 6
The impact of PPAR antagonist GW6471 (10M) on [ 3 H]cholesterol efflux to apoA-I (20g ml -1 ; 24h; n=4), in empty vector (EV) and TSPO transfected macrophages is shown in Figure 6A . Significant differences were determined by one-way ANOVA and Bonferroni post-test.
Efflux to apoA-I (20g ml -1 ; 24h; n=3) in TSPO transfected macrophages simultaneously treated with either negative SiRNA (10nM) or SiRNA (10nM) directed against PPAR is shown in Figure 6B .
Significance between negative SiRNA and PPAR SiRNA in TSPO transfected cells was determined by Student's t-test. In all cases, *p<0.05 compared with the empty vector control; other significant differences are indicated on the Figures. Figure 6C shows a schematic model illustrating the putative pathways by which TSPO overexpression may interface with LXRand PPAR pathways to mediate the observed effects on macrophage lipid phenotype.
